nodes	percent_of_prediction	percent_of_DWPC	metapath
Everolimus—Tacrolimus—PPP3CA—pancreatitis	0.0374	0.928	CrCbGaD
Everolimus—Rash macular—Hyoscyamine—pancreatitis	0.0214	0.0454	CcSEcCtD
Everolimus—Haemoglobin decreased—Hyoscyamine—pancreatitis	0.0127	0.0271	CcSEcCtD
Everolimus—Rash erythematous—Hyoscyamine—pancreatitis	0.0114	0.0243	CcSEcCtD
Everolimus—Ageusia—Hyoscyamine—pancreatitis	0.0108	0.023	CcSEcCtD
Everolimus—Abdominal distension—Propantheline—pancreatitis	0.0108	0.023	CcSEcCtD
Everolimus—Dysphagia—Propantheline—pancreatitis	0.0107	0.0228	CcSEcCtD
Everolimus—Blood disorder—Hyoscyamine—pancreatitis	0.0105	0.0223	CcSEcCtD
Everolimus—Erectile dysfunction—Propantheline—pancreatitis	0.00989	0.021	CcSEcCtD
Everolimus—Gastrooesophageal reflux disease—Hyoscyamine—pancreatitis	0.0097	0.0206	CcSEcCtD
Everolimus—Leukocytosis—Hyoscyamine—pancreatitis	0.00932	0.0198	CcSEcCtD
Everolimus—Skin exfoliation—Hyoscyamine—pancreatitis	0.00837	0.0178	CcSEcCtD
Everolimus—Blood urea increased—Hyoscyamine—pancreatitis	0.00827	0.0176	CcSEcCtD
Everolimus—Flushing—Propantheline—pancreatitis	0.00798	0.017	CcSEcCtD
Everolimus—Rash maculo-papular—Hyoscyamine—pancreatitis	0.00797	0.0169	CcSEcCtD
Everolimus—Pulmonary oedema—Hyoscyamine—pancreatitis	0.0078	0.0166	CcSEcCtD
Everolimus—Vision blurred—Propantheline—pancreatitis	0.00705	0.015	CcSEcCtD
Everolimus—Nasal congestion—Hyoscyamine—pancreatitis	0.00698	0.0148	CcSEcCtD
Everolimus—Atrial fibrillation—Hyoscyamine—pancreatitis	0.00671	0.0143	CcSEcCtD
Everolimus—Palpitations—Propantheline—pancreatitis	0.00661	0.0141	CcSEcCtD
Everolimus—Hypoglycaemia—Hyoscyamine—pancreatitis	0.00652	0.0139	CcSEcCtD
Everolimus—Lethargy—Hyoscyamine—pancreatitis	0.00649	0.0138	CcSEcCtD
Everolimus—Hyponatraemia—Hyoscyamine—pancreatitis	0.00639	0.0136	CcSEcCtD
Everolimus—Dry mouth—Propantheline—pancreatitis	0.00623	0.0132	CcSEcCtD
Everolimus—Irritability—Hyoscyamine—pancreatitis	0.00607	0.0129	CcSEcCtD
Everolimus—Urinary retention—Hyoscyamine—pancreatitis	0.00605	0.0129	CcSEcCtD
Everolimus—Cardiac arrest—Hyoscyamine—pancreatitis	0.00605	0.0129	CcSEcCtD
Everolimus—Tachycardia—Propantheline—pancreatitis	0.00596	0.0127	CcSEcCtD
Everolimus—Dehydration—Hyoscyamine—pancreatitis	0.00592	0.0126	CcSEcCtD
Everolimus—Dry skin—Hyoscyamine—pancreatitis	0.00583	0.0124	CcSEcCtD
Everolimus—Hypokalaemia—Hyoscyamine—pancreatitis	0.00579	0.0123	CcSEcCtD
Everolimus—Abdominal distension—Hyoscyamine—pancreatitis	0.00553	0.0118	CcSEcCtD
Everolimus—Insomnia—Propantheline—pancreatitis	0.00552	0.0117	CcSEcCtD
Everolimus—Dysphagia—Hyoscyamine—pancreatitis	0.0055	0.0117	CcSEcCtD
Everolimus—Somnolence—Propantheline—pancreatitis	0.00543	0.0115	CcSEcCtD
Everolimus—Angina pectoris—Hyoscyamine—pancreatitis	0.00536	0.0114	CcSEcCtD
Everolimus—Constipation—Propantheline—pancreatitis	0.00522	0.0111	CcSEcCtD
Everolimus—Dysuria—Hyoscyamine—pancreatitis	0.00514	0.0109	CcSEcCtD
Everolimus—Erectile dysfunction—Hyoscyamine—pancreatitis	0.00506	0.0108	CcSEcCtD
Everolimus—Feeling abnormal—Propantheline—pancreatitis	0.00503	0.0107	CcSEcCtD
Everolimus—Hyperglycaemia—Hyoscyamine—pancreatitis	0.00496	0.0105	CcSEcCtD
Everolimus—Acute coronary syndrome—Hyoscyamine—pancreatitis	0.00483	0.0103	CcSEcCtD
Everolimus—Myocardial infarction—Hyoscyamine—pancreatitis	0.00481	0.0102	CcSEcCtD
Everolimus—Conjunctivitis—Hyoscyamine—pancreatitis	0.00477	0.0101	CcSEcCtD
Everolimus—Hypersensitivity—Propantheline—pancreatitis	0.0045	0.00957	CcSEcCtD
Everolimus—Asthenia—Propantheline—pancreatitis	0.00438	0.00932	CcSEcCtD
Everolimus—Hallucination—Hyoscyamine—pancreatitis	0.00438	0.00931	CcSEcCtD
Everolimus—Flushing—Hyoscyamine—pancreatitis	0.00408	0.00868	CcSEcCtD
Everolimus—Dizziness—Propantheline—pancreatitis	0.00404	0.00859	CcSEcCtD
Everolimus—Vomiting—Propantheline—pancreatitis	0.00388	0.00826	CcSEcCtD
Everolimus—Mental disorder—Hyoscyamine—pancreatitis	0.00386	0.0082	CcSEcCtD
Everolimus—Rash—Propantheline—pancreatitis	0.00385	0.00819	CcSEcCtD
Everolimus—Dermatitis—Propantheline—pancreatitis	0.00385	0.00818	CcSEcCtD
Everolimus—Erythema—Hyoscyamine—pancreatitis	0.00383	0.00814	CcSEcCtD
Everolimus—Headache—Propantheline—pancreatitis	0.00383	0.00813	CcSEcCtD
Everolimus—Dysgeusia—Hyoscyamine—pancreatitis	0.00375	0.00798	CcSEcCtD
Everolimus—Nausea—Propantheline—pancreatitis	0.00363	0.00771	CcSEcCtD
Everolimus—Vision blurred—Hyoscyamine—pancreatitis	0.00361	0.00768	CcSEcCtD
Everolimus—Agitation—Hyoscyamine—pancreatitis	0.00352	0.00748	CcSEcCtD
Everolimus—Angioedema—Hyoscyamine—pancreatitis	0.0035	0.00744	CcSEcCtD
Everolimus—Syncope—Hyoscyamine—pancreatitis	0.00344	0.0073	CcSEcCtD
Everolimus—Palpitations—Hyoscyamine—pancreatitis	0.00339	0.0072	CcSEcCtD
Everolimus—Loss of consciousness—Hyoscyamine—pancreatitis	0.00337	0.00716	CcSEcCtD
Everolimus—Convulsion—Hyoscyamine—pancreatitis	0.00332	0.00706	CcSEcCtD
Everolimus—Chest pain—Hyoscyamine—pancreatitis	0.00326	0.00693	CcSEcCtD
Everolimus—Anxiety—Hyoscyamine—pancreatitis	0.00325	0.00691	CcSEcCtD
Everolimus—Dry mouth—Hyoscyamine—pancreatitis	0.00319	0.00678	CcSEcCtD
Everolimus—Oedema—Hyoscyamine—pancreatitis	0.00313	0.00665	CcSEcCtD
Everolimus—Shock—Hyoscyamine—pancreatitis	0.00308	0.00654	CcSEcCtD
Everolimus—Tachycardia—Hyoscyamine—pancreatitis	0.00305	0.00649	CcSEcCtD
Everolimus—Hyperhidrosis—Hyoscyamine—pancreatitis	0.00302	0.00643	CcSEcCtD
Everolimus—Hypotension—Hyoscyamine—pancreatitis	0.00292	0.00621	CcSEcCtD
Everolimus—Tacrolimus—ALB—pancreatitis	0.00289	0.0716	CrCbGaD
Everolimus—Insomnia—Hyoscyamine—pancreatitis	0.00283	0.00601	CcSEcCtD
Everolimus—Dyspnoea—Hyoscyamine—pancreatitis	0.00279	0.00593	CcSEcCtD
Everolimus—Somnolence—Hyoscyamine—pancreatitis	0.00278	0.00591	CcSEcCtD
Everolimus—Dyspepsia—Hyoscyamine—pancreatitis	0.00275	0.00585	CcSEcCtD
Everolimus—Fatigue—Hyoscyamine—pancreatitis	0.0027	0.00573	CcSEcCtD
Everolimus—Pain—Hyoscyamine—pancreatitis	0.00267	0.00568	CcSEcCtD
Everolimus—Constipation—Hyoscyamine—pancreatitis	0.00267	0.00568	CcSEcCtD
Everolimus—Feeling abnormal—Hyoscyamine—pancreatitis	0.00258	0.00548	CcSEcCtD
Everolimus—Gastrointestinal pain—Hyoscyamine—pancreatitis	0.00256	0.00544	CcSEcCtD
Everolimus—Body temperature increased—Hyoscyamine—pancreatitis	0.00247	0.00525	CcSEcCtD
Everolimus—Abdominal pain—Hyoscyamine—pancreatitis	0.00247	0.00525	CcSEcCtD
Everolimus—Hypersensitivity—Hyoscyamine—pancreatitis	0.0023	0.0049	CcSEcCtD
Everolimus—Asthenia—Hyoscyamine—pancreatitis	0.00224	0.00477	CcSEcCtD
Everolimus—Pruritus—Hyoscyamine—pancreatitis	0.00221	0.0047	CcSEcCtD
Everolimus—Diarrhoea—Hyoscyamine—pancreatitis	0.00214	0.00455	CcSEcCtD
Everolimus—Dizziness—Hyoscyamine—pancreatitis	0.00207	0.0044	CcSEcCtD
Everolimus—Vomiting—Hyoscyamine—pancreatitis	0.00199	0.00423	CcSEcCtD
Everolimus—Rash—Hyoscyamine—pancreatitis	0.00197	0.00419	CcSEcCtD
Everolimus—Dermatitis—Hyoscyamine—pancreatitis	0.00197	0.00419	CcSEcCtD
Everolimus—Headache—Hyoscyamine—pancreatitis	0.00196	0.00416	CcSEcCtD
Everolimus—Nausea—Hyoscyamine—pancreatitis	0.00186	0.00395	CcSEcCtD
Everolimus—MTOR—Signaling by SCF-KIT—NRAS—pancreatitis	0.000641	0.00131	CbGpPWpGaD
Everolimus—MTOR—Disease—LTF—pancreatitis	0.000639	0.00131	CbGpPWpGaD
Everolimus—MTOR—Insulin receptor signalling cascade—IL6—pancreatitis	0.000631	0.00129	CbGpPWpGaD
Everolimus—MTOR—IGF1R signaling cascade—IL6—pancreatitis	0.000631	0.00129	CbGpPWpGaD
Everolimus—MTOR—NGF signalling via TRKA from the plasma membrane—MDM2—pancreatitis	0.000631	0.00129	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—TLR2—pancreatitis	0.000617	0.00126	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—SCT—pancreatitis	0.000615	0.00126	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—FGG—pancreatitis	0.000615	0.00126	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CASR—pancreatitis	0.000615	0.00126	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling of activated FGFR—NRAS—pancreatitis	0.000613	0.00125	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB4—NRAS—pancreatitis	0.000603	0.00123	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CX3CL1—pancreatitis	0.000603	0.00123	CbGpPWpGaD
Everolimus—MTOR—Immune System—SELL—pancreatitis	0.0006	0.00123	CbGpPWpGaD
Everolimus—MTOR—Senescence and Autophagy in Cancer—HRAS—pancreatitis	0.000593	0.00121	CbGpPWpGaD
Everolimus—MTOR—ErbB1 downstream signaling—HRAS—pancreatitis	0.000593	0.00121	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—MTNR1B—pancreatitis	0.000587	0.0012	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CCK—pancreatitis	0.000587	0.0012	CbGpPWpGaD
Everolimus—MTOR—VEGFA-VEGFR2 Pathway—HRAS—pancreatitis	0.000585	0.00119	CbGpPWpGaD
Everolimus—MTOR—Downstream signal transduction—NRAS—pancreatitis	0.000576	0.00118	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR—NRAS—pancreatitis	0.000573	0.00117	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—TACR1—pancreatitis	0.000572	0.00117	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—A2M—pancreatitis	0.000572	0.00117	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CNR2—pancreatitis	0.000572	0.00117	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB2—NRAS—pancreatitis	0.000571	0.00117	CbGpPWpGaD
Everolimus—MTOR—Senescence and Autophagy in Cancer—IL6—pancreatitis	0.000568	0.00116	CbGpPWpGaD
Everolimus—MTOR—DAP12 signaling—NRAS—pancreatitis	0.000568	0.00116	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CCKAR—pancreatitis	0.000562	0.00115	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—NOD2—pancreatitis	0.00056	0.00114	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—NRAS—pancreatitis	0.00056	0.00114	CbGpPWpGaD
Everolimus—MTOR—VEGFA-VEGFR2 Pathway—IL6—pancreatitis	0.000559	0.00114	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—CD14—pancreatitis	0.000556	0.00114	CbGpPWpGaD
Everolimus—CYP3A4—Tryptophan metabolism—MDM2—pancreatitis	0.000555	0.00113	CbGpPWpGaD
Everolimus—MTOR—Signaling by VEGF—HRAS—pancreatitis	0.000552	0.00113	CbGpPWpGaD
Everolimus—MTOR—Signaling by SCF-KIT—KRAS—pancreatitis	0.000551	0.00113	CbGpPWpGaD
Everolimus—MTOR—Signaling by Insulin receptor—HRAS—pancreatitis	0.000548	0.00112	CbGpPWpGaD
Everolimus—MTOR—Immune System—HSP90AB1—pancreatitis	0.000546	0.00112	CbGpPWpGaD
Everolimus—CYP3A4—Biological oxidations—ALDH2—pancreatitis	0.000545	0.00111	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR in disease—NRAS—pancreatitis	0.000534	0.00109	CbGpPWpGaD
Everolimus—MTOR—Fc epsilon receptor (FCERI) signaling—NRAS—pancreatitis	0.000534	0.00109	CbGpPWpGaD
Everolimus—MTOR—DAP12 interactions—NRAS—pancreatitis	0.000534	0.00109	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR—NRAS—pancreatitis	0.000529	0.00108	CbGpPWpGaD
Everolimus—MTOR—Signaling by VEGF—IL6—pancreatitis	0.000528	0.00108	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling of activated FGFR—KRAS—pancreatitis	0.000528	0.00108	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR in Cancer—NRAS—pancreatitis	0.000525	0.00107	CbGpPWpGaD
Everolimus—MTOR—Signaling by Insulin receptor—IL6—pancreatitis	0.000524	0.00107	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—FGA—pancreatitis	0.000523	0.00107	CbGpPWpGaD
Everolimus—MTOR—Signaling by PDGF—NRAS—pancreatitis	0.000522	0.00107	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—PDGFA—pancreatitis	0.000522	0.00107	CbGpPWpGaD
Everolimus—MTOR—Integrated Breast Cancer Pathway—KRAS—pancreatitis	0.000522	0.00107	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB4—KRAS—pancreatitis	0.000519	0.00106	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—MDM2—pancreatitis	0.000517	0.00106	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—HLA-DQA1—pancreatitis	0.000514	0.00105	CbGpPWpGaD
Everolimus—MTOR—Immune System—CTSL—pancreatitis	0.00051	0.00104	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—PDGFA—pancreatitis	0.000502	0.00103	CbGpPWpGaD
Everolimus—FKBP1A—Disease—PDGFA—pancreatitis	0.000499	0.00102	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PNLIP—pancreatitis	0.000499	0.00102	CbGpPWpGaD
Everolimus—MTOR—Downstream signal transduction—KRAS—pancreatitis	0.000496	0.00101	CbGpPWpGaD
Everolimus—MTOR—B Cell Activation—NRAS—pancreatitis	0.000494	0.00101	CbGpPWpGaD
Everolimus—MTOR—EGF/EGFR Signaling Pathway—KRAS—pancreatitis	0.000493	0.00101	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR—KRAS—pancreatitis	0.000493	0.00101	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB2—KRAS—pancreatitis	0.000491	0.001	CbGpPWpGaD
Everolimus—MTOR—DAP12 signaling—KRAS—pancreatitis	0.000489	0.000999	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—PTHLH—pancreatitis	0.000486	0.000994	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—SMO—pancreatitis	0.000486	0.000994	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—MDM2—pancreatitis	0.000485	0.000991	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—CXCL8—pancreatitis	0.000484	0.000988	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—KRAS—pancreatitis	0.000482	0.000984	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—FGB—pancreatitis	0.000476	0.000972	CbGpPWpGaD
Everolimus—MTOR—NGF signalling via TRKA from the plasma membrane—NRAS—pancreatitis	0.000473	0.000967	CbGpPWpGaD
Everolimus—MTOR—Signaling by SCF-KIT—HRAS—pancreatitis	0.000469	0.000958	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—PPP3CA—pancreatitis	0.000464	0.000948	CbGpPWpGaD
Everolimus—MTOR—BDNF signaling pathway—HRAS—pancreatitis	0.000461	0.000942	CbGpPWpGaD
Everolimus—MTOR—Fc epsilon receptor (FCERI) signaling—KRAS—pancreatitis	0.00046	0.00094	CbGpPWpGaD
Everolimus—MTOR—DAP12 interactions—KRAS—pancreatitis	0.00046	0.00094	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR in disease—KRAS—pancreatitis	0.00046	0.00094	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR—KRAS—pancreatitis	0.000456	0.000931	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR in Cancer—KRAS—pancreatitis	0.000452	0.000923	CbGpPWpGaD
Everolimus—MTOR—Signaling by PDGF—KRAS—pancreatitis	0.00045	0.000919	CbGpPWpGaD
Everolimus—MTOR—Signaling by SCF-KIT—IL6—pancreatitis	0.000449	0.000917	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling of activated FGFR—HRAS—pancreatitis	0.000448	0.000917	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PPY—pancreatitis	0.000448	0.000915	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—SST—pancreatitis	0.000445	0.000909	CbGpPWpGaD
Everolimus—FKBP1A—Disease—LPL—pancreatitis	0.000444	0.000908	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB4—HRAS—pancreatitis	0.000441	0.000902	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—DUSP6—pancreatitis	0.000441	0.000901	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—CASP3—pancreatitis	0.000434	0.000887	CbGpPWpGaD
Everolimus—MTOR—Immune System—TLR3—pancreatitis	0.000433	0.000884	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling of activated FGFR—IL6—pancreatitis	0.000429	0.000877	CbGpPWpGaD
Everolimus—MTOR—B Cell Activation—KRAS—pancreatitis	0.000425	0.00087	CbGpPWpGaD
Everolimus—MTOR—Insulin Signaling—HRAS—pancreatitis	0.000424	0.000866	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB4—IL6—pancreatitis	0.000422	0.000863	CbGpPWpGaD
Everolimus—MTOR—Downstream signal transduction—HRAS—pancreatitis	0.000422	0.000862	CbGpPWpGaD
Everolimus—MTOR—Disease—FGA—pancreatitis	0.00042	0.000858	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR—HRAS—pancreatitis	0.000419	0.000857	CbGpPWpGaD
Everolimus—MTOR—EGF/EGFR Signaling Pathway—HRAS—pancreatitis	0.000419	0.000857	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—BDKRB2—pancreatitis	0.000418	0.000854	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB2—HRAS—pancreatitis	0.000417	0.000853	CbGpPWpGaD
Everolimus—MTOR—DAP12 signaling—HRAS—pancreatitis	0.000415	0.000849	CbGpPWpGaD
Everolimus—MTOR—Immune System—CTSB—pancreatitis	0.000412	0.000841	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CNR1—pancreatitis	0.00041	0.000839	CbGpPWpGaD
Everolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—HRAS—pancreatitis	0.000409	0.000837	CbGpPWpGaD
Everolimus—MTOR—NGF signalling via TRKA from the plasma membrane—KRAS—pancreatitis	0.000407	0.000832	CbGpPWpGaD
Everolimus—MTOR—Downstream signal transduction—IL6—pancreatitis	0.000403	0.000825	CbGpPWpGaD
Everolimus—MTOR—Immune System—PPP3CA—pancreatitis	0.000403	0.000824	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR—IL6—pancreatitis	0.000401	0.000821	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB2—IL6—pancreatitis	0.000399	0.000816	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—CRP—pancreatitis	0.000398	0.000813	CbGpPWpGaD
Everolimus—MTOR—DAP12 signaling—IL6—pancreatitis	0.000398	0.000813	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—GCG—pancreatitis	0.000396	0.00081	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR in disease—HRAS—pancreatitis	0.000391	0.000799	CbGpPWpGaD
Everolimus—MTOR—DAP12 interactions—HRAS—pancreatitis	0.000391	0.000799	CbGpPWpGaD
Everolimus—MTOR—Fc epsilon receptor (FCERI) signaling—HRAS—pancreatitis	0.000391	0.000799	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR—HRAS—pancreatitis	0.000387	0.000792	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR in Cancer—HRAS—pancreatitis	0.000384	0.000785	CbGpPWpGaD
Everolimus—MTOR—Immune System—DUSP6—pancreatitis	0.000383	0.000784	CbGpPWpGaD
Everolimus—MTOR—Signaling by PDGF—HRAS—pancreatitis	0.000382	0.000781	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—TLR4—pancreatitis	0.000381	0.000779	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—KNG1—pancreatitis	0.00038	0.000777	CbGpPWpGaD
Everolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—pancreatitis	0.000374	0.000764	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR in disease—IL6—pancreatitis	0.000374	0.000764	CbGpPWpGaD
Everolimus—MTOR—DAP12 interactions—IL6—pancreatitis	0.000374	0.000764	CbGpPWpGaD
Everolimus—MTOR—Disease—PPP3CA—pancreatitis	0.000372	0.000761	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR—IL6—pancreatitis	0.000371	0.000758	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR in Cancer—IL6—pancreatitis	0.000367	0.000751	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—HLA-DRB1—pancreatitis	0.000366	0.000748	CbGpPWpGaD
Everolimus—MTOR—Signaling by PDGF—IL6—pancreatitis	0.000366	0.000748	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—NRAS—pancreatitis	0.000364	0.000744	CbGpPWpGaD
Everolimus—MTOR—B Cell Activation—HRAS—pancreatitis	0.000362	0.000739	CbGpPWpGaD
Everolimus—MTOR—Immune System—TLR2—pancreatitis	0.00036	0.000735	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—ICAM1—pancreatitis	0.000351	0.000718	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—PDGFA—pancreatitis	0.00035	0.000715	CbGpPWpGaD
Everolimus—MTOR—NGF signalling via TRKA from the plasma membrane—HRAS—pancreatitis	0.000346	0.000707	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—SCT—pancreatitis	0.000346	0.000707	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—FGG—pancreatitis	0.000346	0.000707	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CASR—pancreatitis	0.000346	0.000707	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CX3CL1—pancreatitis	0.000339	0.000693	CbGpPWpGaD
Everolimus—MTOR—Immune System—EGR1—pancreatitis	0.000334	0.000682	CbGpPWpGaD
Everolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—pancreatitis	0.000331	0.000677	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—MTNR1B—pancreatitis	0.00033	0.000674	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CCK—pancreatitis	0.00033	0.000674	CbGpPWpGaD
Everolimus—MTOR—Immune System—NOD2—pancreatitis	0.000326	0.000666	CbGpPWpGaD
Everolimus—MTOR—Immune System—CD14—pancreatitis	0.000324	0.000662	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—A2M—pancreatitis	0.000322	0.000657	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CNR2—pancreatitis	0.000322	0.000657	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—TACR1—pancreatitis	0.000322	0.000657	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CCL5—pancreatitis	0.000318	0.00065	CbGpPWpGaD
Everolimus—FKBP1A—Disease—INS—pancreatitis	0.000318	0.00065	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CCKAR—pancreatitis	0.000316	0.000647	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—KRAS—pancreatitis	0.000313	0.00064	CbGpPWpGaD
Everolimus—MTOR—Immune System—HLA-DQA1—pancreatitis	0.000312	0.000638	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—LPL—pancreatitis	0.000311	0.000636	CbGpPWpGaD
Everolimus—MTOR—Immune System—PDGFA—pancreatitis	0.000304	0.000622	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—SPP1—pancreatitis	0.000295	0.000602	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—FGA—pancreatitis	0.000294	0.000601	CbGpPWpGaD
Everolimus—MTOR—Disease—PDGFA—pancreatitis	0.000281	0.000574	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—HTR2A—pancreatitis	0.00028	0.000573	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—MDM2—pancreatitis	0.000277	0.000566	CbGpPWpGaD
Everolimus—MTOR—Immune System—IL18—pancreatitis	0.000277	0.000565	CbGpPWpGaD
Everolimus—MTOR—Immune System—HGF—pancreatitis	0.000276	0.000563	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PTHLH—pancreatitis	0.000273	0.000559	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—SMO—pancreatitis	0.000273	0.000559	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—IL6—pancreatitis	0.000272	0.000555	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—FGB—pancreatitis	0.000268	0.000547	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—HRAS—pancreatitis	0.000266	0.000544	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—MDM2—pancreatitis	0.000266	0.000543	CbGpPWpGaD
Everolimus—FKBP1A—Disease—MDM2—pancreatitis	0.000265	0.000541	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PPP3CA—pancreatitis	0.000261	0.000533	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—LEP—pancreatitis	0.000261	0.000533	CbGpPWpGaD
Everolimus—FKBP1A—Disease—PTGS2—pancreatitis	0.000255	0.000521	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—IL6—pancreatitis	0.000255	0.000521	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—SST—pancreatitis	0.00025	0.000511	CbGpPWpGaD
Everolimus—MTOR—Disease—LPL—pancreatitis	0.00025	0.00051	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—DUSP6—pancreatitis	0.000248	0.000507	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—BDKRB2—pancreatitis	0.000235	0.00048	CbGpPWpGaD
Everolimus—MTOR—Immune System—CRP—pancreatitis	0.000232	0.000474	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CNR1—pancreatitis	0.000231	0.000472	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—GCG—pancreatitis	0.000223	0.000456	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—INS—pancreatitis	0.000223	0.000455	CbGpPWpGaD
Everolimus—MTOR—Immune System—TLR4—pancreatitis	0.000222	0.000454	CbGpPWpGaD
Everolimus—MTOR—Immune System—HLA-DRB1—pancreatitis	0.000222	0.000453	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CTRB2—pancreatitis	0.00022	0.00045	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CCL2—pancreatitis	0.000219	0.000448	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—KNG1—pancreatitis	0.000214	0.000437	CbGpPWpGaD
Everolimus—MTOR—Immune System—ICAM1—pancreatitis	0.000213	0.000435	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—NRAS—pancreatitis	0.000208	0.000424	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—NRAS—pancreatitis	0.000199	0.000407	CbGpPWpGaD
Everolimus—FKBP1A—Disease—NRAS—pancreatitis	0.000198	0.000406	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PDGFA—pancreatitis	0.000197	0.000402	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—FDX1—pancreatitis	0.000191	0.00039	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—MDM2—pancreatitis	0.000185	0.000379	CbGpPWpGaD
Everolimus—FKBP1A—Disease—TGFB1—pancreatitis	0.000184	0.000377	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CCL5—pancreatitis	0.000179	0.000366	CbGpPWpGaD
Everolimus—MTOR—Disease—INS—pancreatitis	0.000179	0.000366	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—KRAS—pancreatitis	0.000179	0.000365	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ADH4—pancreatitis	0.000178	0.000363	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—LPL—pancreatitis	0.000175	0.000357	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CXCL8—pancreatitis	0.000173	0.000354	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—KRAS—pancreatitis	0.000172	0.000351	CbGpPWpGaD
Everolimus—FKBP1A—Disease—KRAS—pancreatitis	0.000171	0.000349	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PRSS1—pancreatitis	0.000167	0.000341	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CASP3—pancreatitis	0.000166	0.000339	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—SPP1—pancreatitis	0.000166	0.000339	CbGpPWpGaD
Everolimus—MTOR—Immune System—MDM2—pancreatitis	0.000161	0.000329	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PRSS3—pancreatitis	0.000158	0.000323	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PNLIP—pancreatitis	0.000158	0.000323	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—HTR2A—pancreatitis	0.000158	0.000322	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—HRAS—pancreatitis	0.000152	0.00031	CbGpPWpGaD
Everolimus—MTOR—Disease—MDM2—pancreatitis	0.000149	0.000304	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—LEP—pancreatitis	0.000147	0.0003	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—HRAS—pancreatitis	0.000146	0.000298	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—IL6—pancreatitis	0.000145	0.000297	CbGpPWpGaD
Everolimus—FKBP1A—Disease—HRAS—pancreatitis	0.000145	0.000297	CbGpPWpGaD
Everolimus—MTOR—Immune System—IL1B—pancreatitis	0.000145	0.000295	CbGpPWpGaD
Everolimus—MTOR—Disease—PTGS2—pancreatitis	0.000143	0.000293	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—XDH—pancreatitis	0.000142	0.00029	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—NRAS—pancreatitis	0.000139	0.000284	CbGpPWpGaD
Everolimus—FKBP1A—Disease—IL6—pancreatitis	0.000139	0.000284	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ADH1B—pancreatitis	0.000132	0.000271	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—TGFB1—pancreatitis	0.000129	0.000264	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—INS—pancreatitis	0.000125	0.000256	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CCL2—pancreatitis	0.000123	0.000252	CbGpPWpGaD
Everolimus—MTOR—Immune System—NRAS—pancreatitis	0.000121	0.000247	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—KRAS—pancreatitis	0.00012	0.000244	CbGpPWpGaD
Everolimus—MTOR—Disease—NRAS—pancreatitis	0.000112	0.000228	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PLA2G1B—pancreatitis	0.000106	0.000216	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—MDM2—pancreatitis	0.000104	0.000213	CbGpPWpGaD
Everolimus—MTOR—Immune System—KRAS—pancreatitis	0.000104	0.000213	CbGpPWpGaD
Everolimus—MTOR—Disease—TGFB1—pancreatitis	0.000104	0.000212	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—A2M—pancreatitis	0.000102	0.000208	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—HRAS—pancreatitis	0.000102	0.000208	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CXCL8—pancreatitis	9.74e-05	0.000199	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—IL6—pancreatitis	9.73e-05	0.000199	CbGpPWpGaD
Everolimus—MTOR—Disease—KRAS—pancreatitis	9.61e-05	0.000196	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ALDH2—pancreatitis	9.33e-05	0.000191	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CASP3—pancreatitis	9.32e-05	0.000191	CbGpPWpGaD
Everolimus—MTOR—Immune System—HRAS—pancreatitis	8.84e-05	0.000181	CbGpPWpGaD
Everolimus—MTOR—Immune System—IL6—pancreatitis	8.46e-05	0.000173	CbGpPWpGaD
Everolimus—MTOR—Disease—HRAS—pancreatitis	8.16e-05	0.000167	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—NRAS—pancreatitis	7.82e-05	0.00016	CbGpPWpGaD
Everolimus—MTOR—Disease—IL6—pancreatitis	7.81e-05	0.00016	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—TGFB1—pancreatitis	7.26e-05	0.000148	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—GCG—pancreatitis	7.07e-05	0.000144	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—KRAS—pancreatitis	6.73e-05	0.000137	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—HRAS—pancreatitis	5.72e-05	0.000117	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—LPL—pancreatitis	5.55e-05	0.000113	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—IL6—pancreatitis	5.47e-05	0.000112	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PPARG—pancreatitis	4.05e-05	8.28e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—INS—pancreatitis	3.97e-05	8.12e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ALB—pancreatitis	3.64e-05	7.44e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PTGS2—pancreatitis	3.19e-05	6.51e-05	CbGpPWpGaD
